Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing

Psychopharmacology (Berl). 1995 Jun;119(3):315-24. doi: 10.1007/BF02246298.

Abstract

The effects of a single dose of scopolamine (0.5 mg) SC and of lorazepam (2.5 mg) PO were tested in two independent studies for their effects on performance in a psychometric battery which measured functions related to different stages of information processing. Attention and vigilance were measured by a continuous attention task and a vigilance task, respectively. Working memory and reasoning were evaluated by the rapid information processing and logical reasoning task; memory acquisition and storage were measured by pre- and post-drug immediate and delayed recall using visual material. The following pattern of effects was revealed; both scopolamine and lorazepam impaired performance in attentional and vigilance tasks as well as in the rapid information processing task significantly (P < 0.05) when compared with their own placebo; in the logical reasoning task lorazepam significantly prolonged the time required to solve a problem; scopolamine did not have any effect on this task. Scopolamine impaired performance in the immediate recall but left delayed recall unaffected; lorazepam impaired only delayed recall, immediate recall remaining unaffected. These data suggest that scopolamine at this dose impaired mostly attention and early stages of information processes; lorazepam at the dose tested impaired also the later acquisition and encoding aspects of memory.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Affect / drug effects
  • Attention / drug effects
  • Double-Blind Method
  • Humans
  • Lorazepam / pharmacology*
  • Memory / drug effects*
  • Photic Stimulation
  • Psychiatric Status Rating Scales
  • Psychometrics
  • Scopolamine / pharmacology*
  • Task Performance and Analysis
  • Time Factors

Substances

  • Scopolamine
  • Lorazepam